rs2230577

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004560.4(ROR2):​c.2154C>T​(p.Pro718Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0718 in 1,613,426 control chromosomes in the GnomAD database, including 4,883 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.062 ( 422 hom., cov: 33)
Exomes 𝑓: 0.073 ( 4461 hom. )

Consequence

ROR2
NM_004560.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -6.34

Publications

11 publications found
Variant links:
Genes affected
ROR2 (HGNC:10257): (receptor tyrosine kinase like orphan receptor 2) The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors. The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development. Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008]
ROR2 Gene-Disease associations (from GenCC):
  • brachydactyly type B1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive Robinow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-91724340-G-A is Benign according to our data. Variant chr9-91724340-G-A is described in ClinVar as Benign. ClinVar VariationId is 159816.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.34 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ROR2NM_004560.4 linkc.2154C>T p.Pro718Pro synonymous_variant Exon 9 of 9 ENST00000375708.4 NP_004551.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ROR2ENST00000375708.4 linkc.2154C>T p.Pro718Pro synonymous_variant Exon 9 of 9 1 NM_004560.4 ENSP00000364860.3
ROR2ENST00000375715.5 linkc.1734C>T p.Pro578Pro synonymous_variant Exon 9 of 13 1 ENSP00000364867.1
ROR2ENST00000550066.5 linkn.2622C>T non_coding_transcript_exon_variant Exon 11 of 11 2

Frequencies

GnomAD3 genomes
AF:
0.0618
AC:
9398
AN:
152180
Hom.:
416
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0145
Gnomad AMI
AF:
0.0526
Gnomad AMR
AF:
0.0938
Gnomad ASJ
AF:
0.0570
Gnomad EAS
AF:
0.145
Gnomad SAS
AF:
0.107
Gnomad FIN
AF:
0.109
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0664
Gnomad OTH
AF:
0.0766
GnomAD2 exomes
AF:
0.0855
AC:
21384
AN:
250022
AF XY:
0.0851
show subpopulations
Gnomad AFR exome
AF:
0.0136
Gnomad AMR exome
AF:
0.128
Gnomad ASJ exome
AF:
0.0549
Gnomad EAS exome
AF:
0.152
Gnomad FIN exome
AF:
0.105
Gnomad NFE exome
AF:
0.0661
Gnomad OTH exome
AF:
0.0759
GnomAD4 exome
AF:
0.0729
AC:
106494
AN:
1461128
Hom.:
4461
Cov.:
91
AF XY:
0.0737
AC XY:
53571
AN XY:
726940
show subpopulations
African (AFR)
AF:
0.0118
AC:
396
AN:
33480
American (AMR)
AF:
0.122
AC:
5452
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0559
AC:
1460
AN:
26136
East Asian (EAS)
AF:
0.141
AC:
5583
AN:
39698
South Asian (SAS)
AF:
0.107
AC:
9189
AN:
86258
European-Finnish (FIN)
AF:
0.102
AC:
5383
AN:
52670
Middle Eastern (MID)
AF:
0.0565
AC:
326
AN:
5768
European-Non Finnish (NFE)
AF:
0.0667
AC:
74176
AN:
1112008
Other (OTH)
AF:
0.0750
AC:
4529
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
6927
13854
20781
27708
34635
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2864
5728
8592
11456
14320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0618
AC:
9415
AN:
152298
Hom.:
422
Cov.:
33
AF XY:
0.0654
AC XY:
4868
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0144
AC:
599
AN:
41570
American (AMR)
AF:
0.0939
AC:
1437
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0570
AC:
198
AN:
3472
East Asian (EAS)
AF:
0.144
AC:
747
AN:
5176
South Asian (SAS)
AF:
0.108
AC:
520
AN:
4832
European-Finnish (FIN)
AF:
0.109
AC:
1158
AN:
10614
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0664
AC:
4517
AN:
68008
Other (OTH)
AF:
0.0844
AC:
178
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
464
928
1393
1857
2321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0624
Hom.:
507
Bravo
AF:
0.0571
Asia WGS
AF:
0.139
AC:
481
AN:
3478
EpiCase
AF:
0.0642
EpiControl
AF:
0.0649

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 10, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Autosomal recessive Robinow syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Brachydactyly type B1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.034
DANN
Benign
0.60
PhyloP100
-6.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2230577; hg19: chr9-94486622; API